Olema Pharmaceuticals (OLMA) Capital Expenditures (2020 - 2024)

Olema Pharmaceuticals (OLMA) has 4 years of Capital Expenditures data on file, last reported at $6000.0 in Q2 2024.

• On a quarterly basis, Capital Expenditures changed N/A year-over-year to $6000.0 in Q2 2024; TTM through Sep 2025 was $6000.0, a 98.19% decrease from a year earlier, with the FY2024 full-year figure at $159000.0, changed N/A from the prior year.
• Capital Expenditures for Q2 2024 stood at $6000.0, down from $153000.0 in the prior quarter.
• Over the last five years, Capital Expenditures for OLMA reached as high as $813000.0 in Q3 2021 and fell as low as -$10000.0 in Q3 2020.
• Historically, Capital Expenditures has averaged $153785.7 across 4 years, with a median of $34500.0 in 2021.
• Across the five-year window, Capital Expenditures surged 8230.0% in 2021 and plunged 82.9% in 2022, its largest moves.
• Year by year, Capital Expenditures stood at $51000.0 in 2020, then surged by 1270.59% to $699000.0 in 2021, then plunged by 75.25% to $173000.0 in 2022, then sank by 96.53% to $6000.0 in 2024.
• Per Business Quant data, the three most recent Capital Expenditures figures were $6000.0 in Q2 2024, $153000.0 in Q1 2024, and $173000.0 in Q4 2022.